Revenues Working Against FibroGen, Inc.'s (NASDAQ:FGEN) Share Price Following 44% Dive

To the annoyance of some shareholders, FibroGen, Inc. (NASDAQ:FGEN) shares are down a considerable 44% in the last month, which continues a horrid run for the company. For any long-term shareholder

Simply Wall StJul 4 18:07

Express News | FibroGen Inc Files for Mixed Shelf of up to $300 Mln - SEC Filing

BreakingsJun 29 05:09

Goldman Sachs Maintains FibroGen(FGEN.US) With Sell Rating

Goldman Sachs analyst Paul Choi maintains $FibroGen(FGEN.US)$ with a sell rating.According to TipRanks data, the analyst has a success rate of 48.5% and a total average return of 5.1% over the past ye

Futu NewsJun 27 03:31 · Ratings

Favourable Signals For FibroGen: Numerous Insiders Acquired Stock

Yahoo FinanceJun 18 21:02

FibroGen to Host Part II of Virtual KOL Investor Event Series to Review FG-3246 Development Program in Metastatic Castration-Resistant Prostate Cancer on June 26, 2024

SAN FRANCISCO, June 18, 2024 (GLOBE NEWSWIRE) -- FibroGen, Inc. (NASDAQ:FGEN) today announced it will host the second part of its virtual KOL investor event series on Wednesday, June 26, 2024 at 10:00 AM ET. To

GlobeNewswireJun 18 20:00

FibroGen(FGEN.US) Officer Buys US$25,883.91 in Common Stock

$FibroGen(FGEN.US)$ Officer Adib Deyaa purchased 22,123 shares of common stock on Jun 12, 2024 at an average price of $1.17 for a total value of $25,883.91.Source: Announcement What is statement of ch

Futu NewsJun 14 05:12